Hypotension associated with clozapine after cardiopulmonary bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 13, Issue 5, 1999, Pages 597-599

  Donnelly, John G ^a,b   MacLeod, Alexander D ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Cardiopulmonary bypass; Clozapine; Hypotension; Schizophrenia

Indexed keywords

ADRENALIN; ATENOLOL; CLOZAPINE; DOPAMINE; HALOPERIDOL; ISOSORBIDE DINITRATE; METARAMINOL; METHOXAMINE; NORADRENALIN;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CASE REPORT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPOTENSION; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0032862534     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(99)90016-2     Document Type: Article

References (21)

1. Pickar D: Prospects for the pharmacotherapy of schizophrenia. Lancet 345:557-562, 1995
2. ABPI Compendium of Data Sheets and Summaries of Product Characteristics, 1998-1999 Edition. London, UK, Datapharm Publications Ltd, pp 809-811
3. Kane JM, Woerner M, Borenstein M, et al: Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacol Bull 22:254-258, 1986
4. Kane JM: Treatment of schizophrenia. Schizophr Bull 13:133-156, 1987
5. Talbot JA, Goldmann HH, Ross L: Schizophrenia: An economic perspective. Psychiatr Ann 17:577-579, 1987
6. Rupp A, Keith SJ: The costs of schizophrenia: Assessing the burden. Psychiatr Clin North Am 16:413-423, 1993
7. Caldwell CB, Gottesman II: Schizophrenia, a high risk factor for suicide: Clues to risk reduction. Suicide Life Threat Behav 22:479-493, 1992
8. Kane J, Honigfield G, Singer J, Meltzer H, and the Clozaril Collaborative Study Group: Clozapine for the treatment-resistant schizophrenic: A double-blind comparison versus chlorpromazine/benztropine. Arch Gen Psychiatry 45:789-796, 1988
9. Pickar D, Owen RR, Litman RE, et al: Clinical and biological response to clozapine in patients with schizophrenia: Crossover comparison with fluphenazine. Arch Gen Psychiatry 49:345-353, 1992
10. Breier A, Buchanan RW, Kirkpatrick B, et al: Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 151:20-24, 1994
11. Meltzer HY, Okayli G: Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry 152:183-190, 1995
12. Kane JM, Woerner M, Safferman A, et al: Does clozapine cause tardive dyskinesia? J Clin Psychiatry 54:327-330, 1993
13. Green AI, Schildkraut JJ: Should clozapine be a first-line treatment for schizophrenia? The rationale for a double-blind clinical trial in first-episode patients. Harvard Review of Psychiatry 3:1-9, 1995
14. Rang HP, Dale MM: Neuroleptic drugs, in Rang HP, Dale MM (eds): Pharmacology. Edinburgh, UK, Churchill Livingstone, 1991, pp 643-659
15. Russell RM, Jones RM: Postoperative hypotension associated with enalapril. Anaesthesia 44:837-838, 1989
16. McConachie I, Healy TEJ: ACE inhibitors and anesthesia. Postgrad Med J 65:273-274, 1989
17. Colson P, Saussine M, Seguin J, et al: Haemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 74:805-808, 1992
18. Kellow NH: The renin-angiotensin system and angiotensin converting enzyme inhibitors. Anaesthesia 49:613-622, 1994
19. Boldt J, Schindler E, Wollbruck M, et al: Cardiorespiratory response of intravenous angiotensin-converting enzyme inhibitor enalaprilat in hypertensive cardiac surgery patients. J Cardiothorac Vasc Anesth 9:44-49, 1995
20. Tuman KJ, McCarthy RJ, O'Connor CJ, et al: Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg 80:473-479, 1995
21. Ekblom B, Eriksson K, Lindstrom LH: Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal. Psychopharmacology 83:293-294, 1984